MTOR gene polymorphism may be associated with microscopic polyangiitis susceptibility in a Guangxi population of China.

[1]  M. Anagnostouli,et al.  The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data , 2022, International journal of molecular sciences.

[2]  R. Falk,et al.  Mechanisms of vascular damage in ANCA vasculitis , 2022, Seminars in Immunopathology.

[3]  Hong Pan,et al.  Associations of Genetic Polymorphisms of mTOR rs2295080 T/G and rs1883965 G/A with Susceptibility of Urinary System Cancers , 2022, Disease markers.

[4]  J. Long,et al.  Association of MTOR and PDGFRA gene polymorphisms with different degrees of myopia severity. , 2022, Experimental eye research.

[5]  Yan Zhu,et al.  Gene polymorphisms in ULK1 and PIK3CA are associated with the risk of microscopic polyangiitis in the Guangxi Zhuang Autonomous Region in China , 2021, PeerJ.

[6]  J. Andersen,et al.  mTORC2: The other mTOR in autophagy regulation , 2021, Aging cell.

[7]  J. Farrés,et al.  Targeting autophagy in disease: established and new strategies , 2021, Autophagy.

[8]  K. Kaarniranta,et al.  Autophagy Genes for Wet Age-Related Macular Degeneration in a Finnish Case-Control Study , 2020, Genes.

[9]  Xin Huang,et al.  Impact of mTOR gene polymorphisms and gene-tea interaction on susceptibility to tuberculosis , 2020, World journal of clinical cases.

[10]  M. Nematollahi,et al.  Effects of the mTOR and AKT genes polymorphisms on systemic lupus erythematosus risk , 2020, Molecular Biology Reports.

[11]  P. Merkel,et al.  ANCA-associated vasculitis , 2020, Nature Reviews Disease Primers.

[12]  D. Geetha,et al.  ANCA-Associated Vasculitis: Core Curriculum 2020. , 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  A. Perl,et al.  Metabolic pathways mediate pathogenesis and offer targets for treatment in rheumatic diseases. , 2019, Current opinion in rheumatology.

[14]  Jingjing He,et al.  Advances in systemic lupus erythematosus pathogenesis via mTOR signaling pathway. , 2019, Seminars in arthritis and rheumatism.

[15]  Hong Zhang,et al.  Autophagy in Immune-Related Renal Disease , 2019, Journal of immunology research.

[16]  Min Chen,et al.  Risk HLA class II alleles and amino acid residues in myeloperoxidase-ANCA-associated vasculitis. , 2019, Kidney international.

[17]  A. Karras.  Microscopic Polyangiitis: New Insights into Pathogenesis, Clinical Features and Therapy , 2018, Seminars in Respiratory and Critical Care Medicine.

[18]  V. Deretic,et al.  Autophagy balances inflammation in innate immunity , 2018, Autophagy.

[19]  Fengchun Zhang,et al.  HLA‐DPB1 variant rs3117242 is associated with anti‐neutrophil cytoplasmic antibody‐associated vasculitides in a Han Chinese population , 2017, International journal of rheumatic diseases.

[20]  Naoto Hirano,et al.  Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis , 2017, Arthritis & rheumatology.

[21]  I. Ben-Sahra,et al.  mTORC1 signaling and the metabolic control of cell growth. , 2017, Current opinion in cell biology.

[22]  Min Chen,et al.  Autophagy is induced by anti-neutrophil cytoplasmic Abs and promotes neutrophil extracellular traps formation , 2016, Innate immunity.

[23]  Min Chen,et al.  The Prevalence and Management of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in China , 2015, Kidney Diseases.

[24]  Menghong Sun,et al.  Genetic variations in the mTOR gene contribute toward gastric adenocarcinoma susceptibility in an Eastern Chinese population , 2015, Pharmacogenetics and genomics.

[25]  Zhao Zhong （兆忠） Chong （种）.  mTOR: A Novel Therapeutic Target for Diseases of Multiple Systems. , 2015, Current drug targets.

[26]  L. Wang,et al.  Neutrophil extracellular trap formation is associated with autophagy‐related signalling in ANCA‐associated vasculitis , 2015, Clinical and experimental immunology.

[27]  K. Guan,et al.  mTOR: a pharmacologic target for autophagy regulation. , 2015, The Journal of clinical investigation.

[28]  Shizuo Akira,et al.  Autophagy in infection, inflammation and immunity , 2013, Nature Reviews Immunology.

[29]  Q. Wei,et al.  Polymorphisms in the mTOR Gene and Risk of Sporadic Prostate Cancer in an Eastern Chinese Population , 2013, PloS one.

[30]  Menghong Sun,et al.  Polymorphisms in mTORC1 Genes Modulate Risk of Esophageal Squamous Cell Carcinoma in Eastern Chinese Populations , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[31]  W. Gong,et al.  A Polymorphism (rs2295080) in mTOR Promoter Region and Its Association with Gastric Cancer in a Chinese Population , 2013, PloS one.

[32]  P. Shao,et al.  A Functional Variant in the MTOR Promoter Modulates Its Expression and Is Associated with Renal Cell Cancer Risk , 2012, PloS one.

[33]  Panos Deloukas,et al.  Genetically distinct subsets within ANCA-associated vasculitis. , 2012, The New England journal of medicine.

[34]  K. O'Byrne,et al.  Overexpression of the mammalian target of rapamycin (mTOR) and angioinvasion are poor prognostic factors in early stage NSCLC: a verification study. , 2012, Lung cancer.

[35]  E. Ortona,et al.  mTOR signaling and metabolic regulation of T cells: new potential therapeutic targets in autoimmune diseases. , 2011, Current pharmaceutical design.

[36]  Min Chen,et al.  The association of HLA-DRB1 alleles with antineutrophil cytoplasmic antibody-associated systemic vasculitis in Chinese patients. , 2011, Human immunology.

[37]  Teri A Manolio,et al.  Genomewide association studies and assessment of the risk of disease. , 2010, The New England journal of medicine.

[38]  R. Ionescu,et al.  PI3K/Akt signaling in peripheral T lymphocytes from systemic lupus erythematosus patients. , 2009, Roumanian archives of microbiology and immunology.

[39]  D. Scott,et al.  Renal vasculitis in Japan and the UK--are there differences in epidemiology and clinical phenotype? , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[40]  Jun Zhu,et al.  A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. , 2007, American journal of human genetics.

[41]  Joan Valls,et al.  SNPStats: a web tool for the analysis of association studies , 2006, Bioinform..

[42]  F. Yu,et al.  Cinical and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre , 2005, Postgraduate Medical Journal.

[43]  Lin He,et al.  SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci , 2005, Cell Research.

[44]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[45]  D. Scott,et al.  Epidemiology of vasculitis in Europe , 2001, Annals of the rheumatic diseases.

[46]  P. Merkel,et al.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. , 2013, Arthritis and rheumatism.

[47]  Tao Li,et al.  A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn) , 2009, Cell Research.